论文部分内容阅读
新生儿ABO溶血症,是一种常见而潜在的重症疾患.由于母体的抗A或抗B抗体,作用于相应的新生儿红细胞而产生溶血.新生儿红细胞的破坏,可导致血胆红素过多和贫血,如忽略可能引起脑病,甚至核黄疸而死亡.即使发现为治疗高胆红素血症和贫血,给予的光疗和/或输血,也存在本身固有的危险.因为新生儿ABO溶血症一般比Rh血型不合轻,不需要胎儿期监护,故在常规产前普查中易漏过.本文目的是确定疾病再发的危险,和讨论追踪高危再发病人的方式.
Newborn ABO hemolytic disease is a common and potentially serious condition that results in hemolysis due to maternal anti-A or anti-B antibodies acting on the corresponding neonatal red blood cells.The destruction of neonatal red blood cells can lead to hyperbilirubinemia And anemia, if ignored, may cause encephalopathy and even death from kernicterus Even if phototherapy and / or blood transfusions are found for the treatment of hyperbilirubinemia and anemia, there is inherent risk that neonatal ABO hemolytic disease Generally less than Rh blood group incompatibility, does not require fetal monitoring, it is easily missed in routine prenatal censuses.The purpose of this paper is to determine the risk of disease recurrence, and to discuss ways to track high-risk recurrence of patients.